CoChat

Physiological and pathophysiological actions of insulin in the liver

Open access
Kubota, Naoto, Kubota, Tetsuya, Kadowaki, Takashi · 2025 · Endocrine Journal

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Abstract

The liver plays an important role in the control of glucose homeostasis. When insulin levels are low, such as in the fasting state, gluconeogenesis and glycogenolysis are stimulated to maintain the blood glucose levels. Conversely, in the presence of increased insulin levels, such as after a meal, synthesis of glycogen and lipid occurs to maintain the blood glucose levels within normal range. Insulin receptor signaling regulates glycogenesis, gluconeogenesis and lipogenesis through downstream pathways such as the insulin receptor substrate (IRS)-phosphoinositide 3 (PI3) kinase-Akt pathway. IRS-1 and IRS-2 are abundantly expressed in the liver and are thought to be responsible for transmitting the insulin signal from the insulin receptor to the intracellular effectors involved in the regulation of glucose and lipid homeostasis. Impaired insulin receptor signaling can cause hepatic insulin resistance and lead to type 2 diabetes. In the present study, we focus on a concept called "selective insulin resistance," which has received increasing attention recently: the frequent coexistence of hyperglycemia and hepatic steatosis in people with type 2 diabetes and obesity suggests that it is possible for the insulin signaling regulating gluconeogenesis to be impaired even while that regulating lipogenesis is preserved, suggestive of selective insulin resistance. In this review, we review the progress in research on the insulin actions and insulin signaling in the liver.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1507/endocrj.ej24-0192

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Insulin receptor signaling cascades in the liver Insulin plays a crucial role in the regulation of glycogen synthesis (glycogenesis), gluconeogenesis (hepatic glucose production), and de novo fatty acid synthesis (lipogenesis) in the liver through the mediation of the insulin receptor, IRSs, and their downstream pathways in the liver.
Fig. 1 Insulin receptor signaling cascades in the liver Insulin plays a crucial role in the regulation of glycogen synthesis (glycogenesis), gluconeogenesis (hepatic glucose production), and de novo fatty acid synthesis (lipogenesis) in the liver through the mediation of the insulin receptor, IRSs, and their downstream pathways in the liver.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 120 references

Cited by

Metadata

Authors
Kubota, N., Kubota, T., & Kadowaki, T.
Affiliations
  • Kumamoto University (JP)
  • The Institute of Medical Science, Asahi Life Foundation (JP)
  • Toranomon Hospital (JP)
Corresponding author
Kubota, Naoto
Venue
Endocrine Journal
Published
2025
Volume
72
Issue
2
Pages
149-159
ISSN
  • 0918-8959 (ISSN-L)
  • 1348-4540
OpenAlex
W4402120026
Cited by
19
References
115
Citations by year
2026: 12 · 2025: 7
FWCI
0.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Endocrine Journal (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Japan Society for the Promotion of Science (24K02500)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
insulin signaling, liver, glucose homeostasis, gluconeogenesis, glycogen synthesis, lipogenesis, hepatic insulin resistance, insulin receptor substrate, PI3K/Akt signaling, type 2 diabetes, hepatic steatosis, obesity
MeSH terms
Animals, Diabetes Mellitus, Type 2, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Receptor, Insulin, Signal Transduction, Lipogenesis, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.